Download Genetic Risk Assessment - Transition Technologies SA

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project

Document related concepts

NEDD9 wikipedia , lookup

Nutriepigenomics wikipedia , lookup

Pharmacogenomics wikipedia , lookup

Public health genomics wikipedia , lookup

Genetic testing wikipedia , lookup

Medical genetics wikipedia , lookup

BRCA mutation wikipedia , lookup

Genome (book) wikipedia , lookup

Oncogenomics wikipedia , lookup

Transcript
Genetic Risk Assessment
The computer system for the identification of hereditary cancer high-risk groups
and the formulation of cancer prevention recommendations.
www.tt.com.pl
www.mi.tt.com.pl/en/medical-intelligence/genetic-risk-assessment
Genetic Risk
Assessment
Transition Technologies S.A.
Pawia 55,
01-030 Warsaw, Poland
Tel.: +48 22 439 9232
www.tt.com.pl
Monika Markowska
Product Owner
[email protected]
Mob.: +48 723 208 891
Konrad Wojdan
R&D Team Leader
[email protected]
Mob.: +48 603 910 108
Genetic Risk Assessment is an expert
computer system used to identify highrisk groups for hereditary cancer types
including breast, lung, colon, stomach
and ovarian cancer. The implemented
algorithm analyses the patient’s family
medical history and checks the criteria
for high-risk groups for the aforementioned cancers. If the result is positive,
the patient automatically receives recommendations for cancer prevention
and further instructions to help minimize
the risk of developing the disease.
The knowledge database used by the
system is customized according to medical guidelines. Furthermore, the easyto-use Graphical User Interface allows
straightforward modification of diagnostic criteria and patient recommendations.
This tool is designed specifically for primary care physicians, family doctors,
medical staff from cancer clinics/hospitals and cancer genetics clinics. Thanks
to the Genetic Risk Assessment the
physicians and patients have access to a
tool which enhances cancer prevention in
high-risk families. The intuitive Graphical
User Interface makes the process of filling in the questionnaire and its analysis
much faster and easier. Furthermore,
doctors have constant access to their
patients’ medical history and may easily
review the results of the questionnaire.
The Genetic Risk Assessment solution is available for tablet computers
with Windows 8 operating system and
is obtainable in the Windows Store
www.mi.tt.com.pl/en/medical-intelligence/
genetic-risk-assessment